Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The treatment with trandolapril and losartan attenuates pressure and volume overload alternations of cardiac connexin-43 and extracellular matrix in Ren-2 transgenic rats

M. Sykora, V. Kratky, L. Cervenka, L. Kopkan, N. Tribulova, B. Szeiffova Bacova

. 2023 ; 13 (1) : 20923. [pub] 20231127

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24000605

Grantová podpora
21-0410 Agentúra na Podporu Výskumu a Vývoja
2/0002/20 VEGA
2/0006/23 VEGA
ITMS2014+: 313011AVG3 European Regional Development Fund
00023001 Ministry of Health of the Czech Republic
LX22NPO5104 National Institute for Research of Metabolic and Cardiovascular Diseases (Program EXCELES

Heart failure (HF) is life-threatening disease due to electro-mechanical dysfunction associated with hemodynamic overload, while alterations of extracellular matrix (ECM) along with perturbed connexin-43 (Cx43) might be key factors involved. We aimed to explore a dual impact of pressure, and volume overload due to aorto-caval fistula (ACF) on Cx43 and ECM as well as effect of renin-angiotensin blockade. Hypertensive Ren-2 transgenic rats (TGR) and normotensive Hannover Sprague-Dawley rats (HSD) that underwent ACF were treated for 15-weeks with trandolapril or losartan. Blood serum and heart tissue samples of the right (RV) and left ventricles (LV) were used for analyses. ACF-HF increased RV, LV and lung mass in HSD and to lesser extent in TGR, while treatment attenuated it and normalized serum ANP, BNP-45 and TBARS. Cx43 protein and its ser368 variant along with PKCε were lower in TGR vs HSD and suppressed in both rat strains due to ACF but prevented more by trandolapril. Pro-hypertrophic PKCδ, collagen I and hydroxyproline were elevated in TGR and increased due to ACF in both rat strains. While SMAD2/3 and MMP2 levels were lower in TGR vs HSD and reduced due to ACF in both strains. Findings point out the strain-related differences in response to volume overload. Disorders of Cx43 and ECM signalling may contribute not only to HF but also to the formation of arrhythmogenic substrate. There is benefit of treatment with trandolapril and losartan indicating their pleiotropic anti-arrhythmic potential. It may provide novel input to therapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24000605
003      
CZ-PrNML
005      
20240213093300.0
007      
ta
008      
240109s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-023-48259-2 $2 doi
035    __
$a (PubMed)38017033
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Sykora, Matus $u Centre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 841 04, Bratislava, Slovakia
245    14
$a The treatment with trandolapril and losartan attenuates pressure and volume overload alternations of cardiac connexin-43 and extracellular matrix in Ren-2 transgenic rats / $c M. Sykora, V. Kratky, L. Cervenka, L. Kopkan, N. Tribulova, B. Szeiffova Bacova
520    9_
$a Heart failure (HF) is life-threatening disease due to electro-mechanical dysfunction associated with hemodynamic overload, while alterations of extracellular matrix (ECM) along with perturbed connexin-43 (Cx43) might be key factors involved. We aimed to explore a dual impact of pressure, and volume overload due to aorto-caval fistula (ACF) on Cx43 and ECM as well as effect of renin-angiotensin blockade. Hypertensive Ren-2 transgenic rats (TGR) and normotensive Hannover Sprague-Dawley rats (HSD) that underwent ACF were treated for 15-weeks with trandolapril or losartan. Blood serum and heart tissue samples of the right (RV) and left ventricles (LV) were used for analyses. ACF-HF increased RV, LV and lung mass in HSD and to lesser extent in TGR, while treatment attenuated it and normalized serum ANP, BNP-45 and TBARS. Cx43 protein and its ser368 variant along with PKCε were lower in TGR vs HSD and suppressed in both rat strains due to ACF but prevented more by trandolapril. Pro-hypertrophic PKCδ, collagen I and hydroxyproline were elevated in TGR and increased due to ACF in both rat strains. While SMAD2/3 and MMP2 levels were lower in TGR vs HSD and reduced due to ACF in both strains. Findings point out the strain-related differences in response to volume overload. Disorders of Cx43 and ECM signalling may contribute not only to HF but also to the formation of arrhythmogenic substrate. There is benefit of treatment with trandolapril and losartan indicating their pleiotropic anti-arrhythmic potential. It may provide novel input to therapy.
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a zvířata $7 D000818
650    _2
$a potkani transgenní $7 D055647
650    _2
$a losartan $x farmakologie $7 D019808
650    _2
$a renin $7 D012083
650    _2
$a konexin 43 $x genetika $7 D018031
650    _2
$a potkani Sprague-Dawley $7 D017207
650    12
$a srdeční selhání $7 D006333
650    12
$a hypertenze $7 D006973
650    _2
$a krevní tlak $7 D001794
650    12
$a píštěle $7 D005402
650    _2
$a extracelulární matrix $7 D005109
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kratky, Vojtech $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, 140 21, Prague, Czech Republic $u Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08, Prague, Czech Republic
700    1_
$a Cervenka, Ludek $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, 140 21, Prague, Czech Republic $u Department of Internal Medicine I, Cardiology, University Hospital Olomouc and Palacky University, Olomouc, Czech Republic
700    1_
$a Kopkan, Libor $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, 140 21, Prague, Czech Republic
700    1_
$a Tribulova, Narcis $u Centre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 841 04, Bratislava, Slovakia
700    1_
$a Szeiffova Bacova, Barbara $u Centre of Experimental Medicine, Institute for Heart Research, Slovak Academy of Sciences, 841 04, Bratislava, Slovakia. barbara.bacova@savba.sk
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 13, č. 1 (2023), s. 20923
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38017033 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240213093258 $b ABA008
999    __
$a ok $b bmc $g 2049328 $s 1210299
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 13 $c 1 $d 20923 $e 20231127 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
GRA    __
$a 21-0410 $p Agentúra na Podporu Výskumu a Vývoja
GRA    __
$a 2/0002/20 $p VEGA
GRA    __
$a 2/0006/23 $p VEGA
GRA    __
$a ITMS2014+: 313011AVG3 $p European Regional Development Fund
GRA    __
$a 00023001 $p Ministry of Health of the Czech Republic
GRA    __
$a LX22NPO5104 $p National Institute for Research of Metabolic and Cardiovascular Diseases (Program EXCELES
LZP    __
$a Pubmed-20240109

Najít záznam

Citační ukazatele

Možnosti archivace